nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Flexible Nonlinear Feedback System That Captures Diverse Patterns of Adaptation and Rebound
|
Gabrielsson, Johan |
|
2008 |
10 |
1 |
p. 70-83 |
artikel |
2 |
Announcing AAPS and FDA Agreement to Build Quantitative Alzheimer's Disease Model
|
Inchauteguiz, Peter |
|
2008 |
10 |
1 |
p. 227 |
artikel |
3 |
An Overview of Patent Law as Applied to the Field of Veterinary Medicine
|
Gould, James M. |
|
2007 |
10 |
1 |
p. 1-8 |
artikel |
4 |
Application of Gastrointestinal Simulation for Extensions for Biowaivers of Highly Permeable Compounds
|
Tubic-Grozdanis, Marija |
|
2008 |
10 |
1 |
p. 213-226 |
artikel |
5 |
Cell Cycle Checkpoint Models for Cellular Pharmacology of Paclitaxel and Platinum Drugs
|
El-Kareh, Ardith W. |
|
2007 |
10 |
1 |
p. 15-34 |
artikel |
6 |
Evaluation of Methods for Estimating Time to Steady State with Examples from Phase 1 Studies
|
Maganti, Lata |
|
2008 |
10 |
1 |
p. 141-147 |
artikel |
7 |
FDA Critical Path Initiatives: Opportunities for Generic Drug Development
|
Lionberger, Robert A. |
|
2008 |
10 |
1 |
p. 103-109 |
artikel |
8 |
Highly Variable Drugs: Observations from Bioequivalence Data Submitted to the FDA for New Generic Drug Applications
|
Davit, Barbara M. |
|
2008 |
10 |
1 |
p. 148-156 |
artikel |
9 |
Informatic Tools and Approaches in Postmarketing Pharmacovigilance Used by FDA
|
Weaver, Joyce |
|
2007 |
10 |
1 |
p. 35-41 |
artikel |
10 |
Nanoparticles Containing Anti-inflammatory Agents as Chemotherapy Adjuvants: Optimization and In Vitro Characterization
|
Lu, Xiuling |
|
2008 |
10 |
1 |
p. 133-140 |
artikel |
11 |
Percutaneous Permeation Enhancement by Terpenes: Mechanistic View
|
Sapra, Bharti |
|
2008 |
10 |
1 |
p. 120-132 |
artikel |
12 |
Pharmacogenetic and Metabolic Differences Between Dog Breeds: Their Impact on Canine Medicine and the Use of the Dog as a Preclinical Animal Model
|
Fleischer, Steven |
|
2008 |
10 |
1 |
p. 110-119 |
artikel |
13 |
Pharmacokinetically-Guided Lead Optimization of Nitrofuranylamide Anti-Tuberculosis Agents
|
Budha, Nageshwar R. |
|
2008 |
10 |
1 |
p. 157-165 |
artikel |
14 |
Pharmacokinetic Interaction between the Flavonoid Luteolin and γ-Hydroxybutyrate in Rats: Potential Involvement of Monocarboxylate Transporters
|
Wang, Xiaodong |
|
2007 |
10 |
1 |
p. 47-55 |
artikel |
15 |
Pharmacokinetics of 1,4-Butanediol in Rats: Bioactivation to γ-Hydroxybutyric Acid, Interaction with Ethanol, and Oral Bioavailability
|
Fung, Ho-Leung |
|
2007 |
10 |
1 |
p. 56-69 |
artikel |
16 |
Prodrug Approaches for CNS Delivery
|
Rautio, Jarkko |
|
2008 |
10 |
1 |
p. 92-102 |
artikel |
17 |
Reaction Phenotyping: Current Industry Efforts to Identify Enzymes Responsible for Metabolizing Drug Candidates
|
Harper, Timothy W. |
|
2008 |
10 |
1 |
p. 200-207 |
artikel |
18 |
Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy
|
Bellavance, Marc-André |
|
2008 |
10 |
1 |
p. 166-177 |
artikel |
19 |
Rheological Evaluation of Silicon/Carbopol Hydrophilic Gel Systems as a Vehicle for Delivery of Water Insoluble Drugs
|
Bonacucina, Giulia |
|
2008 |
10 |
1 |
p. 84-91 |
artikel |
20 |
Role of Biotransformation Studies in Minimizing Metabolism-Related Liabilities in Drug Discovery
|
Shu, Yue-Zhong |
|
2008 |
10 |
1 |
p. 178-192 |
artikel |
21 |
Sodium-coupled Monocarboxylate Transporters in Normal Tissues and in Cancer
|
Ganapathy, Vadivel |
|
2008 |
10 |
1 |
p. 193-199 |
artikel |
22 |
The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review
|
González Canga, Aránzazu |
|
2007 |
10 |
1 |
p. 42-46 |
artikel |
23 |
The Role of Quantitative Pharmacology in an Academic Translational Research Environment
|
Barrett, Jeffrey S. |
|
2007 |
10 |
1 |
p. 9-14 |
artikel |
24 |
Use of the Biopharmaceutical Classification System in Early Drug Development
|
Ku, M. Sherry |
|
2008 |
10 |
1 |
p. 208-212 |
artikel |